REPH RECRO PHARMA INC

Societal CDMO to Report Financial Results for Fourth Quarter and Year-End 2022 on March 1, 2023

Societal CDMO to Report Financial Results for Fourth Quarter and Year-End 2022 on March 1, 2023

Webcast Scheduled for Wednesday, March 1, 2023, at 4:30 p.m. Eastern

SAN DIEGO and GAINESVILLE, Ga., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will release financial results for the fourth quarter and year-end 2022 after the market close on Wednesday, March 1, 2023. Societal’s management team will host a webcast at 4:30 p.m. ET on that day to discuss the financial results and recent operational highlights.

A live webcast can be accessed by visiting the “Investor Events” page in the Investor section of the company’s website: . In addition, an archived webcast will be available on the company’s website approximately two hours after the event and will be available for 30 days.

About Societal CDMO

Societal CDMO (NASDAQ: ) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal CDMO is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.

In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, which total 145,000 square feet, in Gainesville, Georgia and San Diego, California.

Societal CDMO: Bringing Science to Society. For more information about Societal CDMO’s customer solutions, visit .



Contacts:
Stephanie Diaz (Investors) 
Vida Strategic Partners  
415-675-7401
  

Tim Brons (Media)
Vida Strategic Partners
415-675-7402
   

Ryan D. Lake (CFO)
Societal CDMO
770-531-8365     
EN
22/02/2023

Underlying

REPHRECRO PHARMA INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RECRO PHARMA INC

 PRESS RELEASE
Free
REPH RECRO PHARMA IN...

CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.

CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc. CLEARWATER, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- CoreRx, Inc. (“CoreRx”) today announced that it has completed its acquisition of Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule therapeutics. The Offer and the MergerCoreRx’s tender offer to acquire all of the issued and outstanding shares of common stock (the “Shares”) of Societal CDMO, at a purchase price of $1.1...

April 8, 2024 1 EN
 PRESS RELEASE
Free
REPH RECRO PHARMA IN...

Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreR...

Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc. Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender Offer for all Outstanding Shares of Societal CDMO, Inc. CLEARWATER, Fla. and GAINESVILLE, Ga., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufa...

February 28, 2024 1 EN
 PRESS RELEASE
Free
REPH RECRO PHARMA IN...

Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Prom...

Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish GAINESVILLE, Ga. and ROUND ROCK, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: ), a contract development and manufacturing organization (CDMO) de...

February 1, 2024 1 EN
 PRESS RELEASE
Free
REPH RECRO PHARMA IN...

Societal CDMO Reports Inducement Grants for New Staff

Societal CDMO Reports Inducement Grants for New Staff SAN DIEGO and GAINESVILLE, Ga., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: ), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced the addition of new employees to fill open roles throughout the organization. Inducement Equity Award In connection with the hiring of these personnel, the compensation committee of Societal CDMO’s board of directors approve...

January 5, 2024 1 EN
 PRESS RELEASE
Free
REPH RECRO PHARMA IN...

Societal CDMO Reports Third Quarter 2023 Financial Results

Societal CDMO Reports Third Quarter 2023 Financial Results Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated Corporate Restructuring; Expected to Result in Annualized Savings of Approximately $5.5 Million Company to Host Webcast Today at 4:30 p.m. ET SAN DIEGO and GAINESVILLE, Ga., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solvin...

November 8, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch